Genomic Health Says Future Lies in Next-Gen Sequencing | GenomeWeb

By Julia Karow

Genomic Health
has been exploring how next-generation sequencing can be harnessed for biomarker discovery in clinical cancer samples, and plans to make its research capabilities available to pharmaceutical partners, for example to develop companion diagnostics.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.